Search the Newsreel

MMSI Maintained by B of A Securities -- Price Target Raised to $97.00

B of A Securities maintained a neutral rating on Merit Medical Systems (MMSI) but raised its price target from $92.00 to $97.00. GuruFocus indicates MMSI is undervalued by 4.9% with a strong GF Score of 86/100, excelling in growth and valuation. While gurus show …

Merit Medical at Bank of America smid cap virtual conference: growth, margins

Merit Medical Systems (MMSI) recently participated in the Bank of America SMID Cap Virtual Conference, where CFO Raul Parra highlighted the company's transition towards stronger growth, wider margins, and a streamlined reporting structure. The company raised its 2024 organic constant-currency revenue growth outlook and …

14-Day Rally Sends Merit Medical Systems Stock Up 25%

The article "14-Day Rally Sends Merit Medical Systems Stock Up 25%" indicates a significant recent increase in the stock value of Merit Medical Systems. However, the provided content is largely boilerplate and does not contain the actual article details regarding this rally. It primarily …

Merit Medical Systems (MMSI) Is Up 6.2% After Raising 2026 Outlook And Q2 Beat Expectations – Has The Bull Case Changed?

Merit Medical Systems (MMSI) saw its stock rise by 6.2% after reporting strong second-quarter 2026 results, including higher sales and net income, and subsequently raising its full-year 2026 revenue outlook. While the upgraded guidance supports stronger near-term earnings, the company still faces risks such …

BofA raises Merit Medical stock price target on growth outlook

BofA Securities has increased its price target for Merit Medical Systems (NASDAQ:MMSI) to $97 from $92, while maintaining a Neutral rating, citing confidence in the company's growth and margin outlook for 2026 and beyond. The firm's decision is based on an increased 2027 earnings …

Assenagon Asset Management S.A. Sells 70,521 Shares of Merit Medical Systems, Inc. $MMSI

Assenagon Asset Management S.A. significantly reduced its stake in Merit Medical Systems (NASDAQ:MMSI) by selling 70,521 shares, lowering its holdings by 34.2%. Despite this reduction, institutional investors collectively own 99.66% of the company, which recently reported strong quarterly earnings exceeding expectations and issued positive …

Merit Medical Systems Stock Climbs 25% On A 13-Day Winning Streak

Merit Medical Systems (MMSI) stock has surged 25% over 13 consecutive trading days, adding $1.1 billion to its market value and bringing its total valuation to $5.4 billion. This impressive streak significantly outperforms the S&P 500's 4.3% gain over the same period, suggesting company-specific …

Why Merit Medical Systems (MMSI) Is Up 14.4% After Raising 2026 Revenue Outlook And Margins

Merit Medical Systems (MMSI) saw its stock rise by 14.4% after reporting strong Q2 2026 results and raising its full-year 2026 revenue outlook to US$1.631 billion–US$1.643 billion. This positive revision is attributed to better-than-expected first-half performance, recent acquisitions, and efficiency gains. While the raised …

Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for Merit Medical Systems (NASDAQ:MMSI), setting a price target of $105, which suggests a 17% upside. The company recently surpassed earnings estimates with an EPS of $1.19 and saw its revenue increase by 9.5% year-over-year to $418.84 …

Gradient Investments LLC Buys Shares of 23,890 Merit Medical Systems, Inc. $MMSI

Gradient Investments LLC has acquired 23,890 shares of Merit Medical Systems, Inc. (NASDAQ:MMSI), valued at approximately $1.66 million, contributing to the significant institutional ownership of 99.66% in the company. Merit Medical Systems recently reported strong quarterly earnings, beating analyst estimates with an EPS of …

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by Brokerages

Merit Medical Systems, Inc. (NASDAQ:MMSI) has received a consensus "Moderate Buy" rating from brokerages, with eight out of eleven analysts recommending a buy and three suggesting a hold. The average 12-month price target is $100.30, exceeding its opening price of $89.04. The company recently …

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Martha Aronson Executive Vice President and Chief Financial Officer - Raul Parra Chief Legal Officer and Corporate Secretary - Brian Lloyd Full …

Merit Medical Systems Chief Operating Officer Neil Peterson Sells 68% Of Holding

Merit Medical Systems' Chief Operating Officer, Neil Peterson, recently sold 68% of his holdings, netting US$1.8m. This significant sale, along with other insider selling activities totaling US$7.3m over the last year, raises some concerns despite the company's profitability and strong insider ownership. While high …

Merit Medical Systems (MMSI) COO Neil Peterson Sells 21,449 Shares

Merit Medical Systems (MMSI) COO Neil Peterson sold 21,449 shares of the company for approximately $1.82 million, reducing his direct ownership to 25,551 shares. This sale is part of a broader insider selling trend, with 9 insider sells versus 5 buys over the past …

Merit Medical to Participate in Upcoming Investors Conferences in August

Merit Medical Systems, Inc. announced its participation in two investor conferences in August 2026. Management will hold fireside chats at the Canaccord Genuity 46th Annual Growth Conference and the Bank of America SMID Cap Conference. Live audio webcasts and replays will be available on …

Two Merit Medical fireside chats will stream live Aug. 11-12

Merit Medical Systems, Inc. (NASDAQ: MMSI) announced its participation in two investor conferences in August 2026. Management will host a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 11 and at the Bank of America SMID Cap Conference on August …

Proposed MMSI (MMSI) insider stock sale disclosed in Form 144 filing

A Form 144 filing indicates a proposed sale of up to 21,449 shares of Merit Medical Systems Inc. (MMSI) common stock by an affiliate. The shares, consisting of Performance Shares and Restricted Stock granted in 2025 and 2026, are expected to be sold on …

Merit Medical Systems (MMSI) Stock Looks Undervalued On Cash Flow But Overvalued On Earnings

The Manufacturers Life Insurance Company Purchases 148,703 Shares of Merit Medical Systems, Inc. $MMSI

Merit Medical (MMSI) Stock Eyes Bigger Growth Run After Profit Outlook Lift

MERIT MEDICAL SYSTEMS INC : NEEDHAM RAISES TARGET PRICE TO $101 FROM $90

Needham has increased its target price for Merit Medical Systems Inc (MMSI.O) from $90 to $101. This update reflects a positive revision in the analyst's outlook for the company. The news was reported by Reuters.

Merit Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MMSI) 2026-07-31

Merit Medical Systems, Inc. (MMSI) released its Q2 2026 earnings call presentation, reporting an EPS of $1.19, which beat estimates by $0.23. The company also reported revenues of $418.84 million, a 9.51% year-over-year increase, beating estimates by $13.50 million. This slide deck accompanies their …

Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $99.82, Implies 20% Upside

Merit Medical Systems, Inc.'s average 12-month price target has been increased to $99.82 from $90.09, based on estimates from 11 analysts. This updated target suggests a potential upside of approximately 20% from the July 30 closing price. The consensus rating for MMSI stock remains …

MERIT MEDICAL SYSTEMS, INC. : WELLS FARGO RAISES TARGET PRICE TO $83 FROM $74

Wells Fargo has increased its target price for MERIT MEDICAL SYSTEMS, INC. (MMSI.O) to $83 from $74. This update was reported by Reuters on July 31, 2026. The article states that the content reflects the author's opinion and is not investment advice.

Merit Medical Systems Q2 Non-GAAP Earnings, Net Sales Rise; Lifts 2026 Guidance

Merit Medical Systems reported increased non-GAAP earnings and net sales for Q2, leading the company to raise its financial guidance for 2026. This positive performance indicates strong operational results and an optimistic outlook for the coming year.

Merit Medical: Q2 Earnings Snapshot

This article provides a brief snapshot of Merit Medical's Q2 earnings. Due to the lack of detailed financial information, specific figures or performance metrics cannot be reported in the summary.

Canaccord raises Merit Medical stock price target on strong Q2 results

Canaccord increased its price target for Merit Medical Systems (NASDAQ:MMSI) to $94 from $85, maintaining a Buy rating after the company reported strong second-quarter results. Merit Medical surpassed revenue and EPS estimates, showing 10% year-over-year revenue growth and its strongest organic growth in three …

Merit Medical Systems (NASDAQ:MMSI) Announces Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

Merit Medical Systems, Inc. announced strong financial results for the second quarter of 2026, surpassing expectations with a 9% organic, constant currency revenue growth. The company reported a 10% increase in U.S. sales and improved non-GAAP operating margin and EPS. Reflecting these robust results, …

Earnings call transcript: Merit Medical tops Q2 2026 estimates and lifts outlook

Merit Medical Systems reported strong Q2 2026 results, exceeding Wall Street expectations for profit and sales with adjusted earnings of $1.19 per share and revenue of $418.8 million. The company also raised its full-year outlook, citing its strongest organic growth in three years and …

Merit Medical posts Q2 beat, raises FY26 EPS and sales guidance

Merit Medical Systems exceeded its Q2 2026 expectations with $418.8 million in revenue, a 10% increase year-over-year, and non-GAAP EPS of $1.19, up 18%. This strong performance, driven by robust U.S. demand and margin expansion, led the company to raise its full-year 2026 adjusted …

Merit Medical Systems (NASDAQ:MMSI) Jumps After Q2 Earnings Beat and Revenue Slightly Ahead of Estimates

Merit Medical Systems (NASDAQ:MMSI) reported strong second-quarter 2026 results, with non-GAAP EPS of $1.19 significantly beating analyst estimates of $0.9782 and revenue of $418.8 million slightly exceeding projections. This performance, driven by strength in cardiovascular and endoscopy segments, led to a positive market reaction …

(MMSI) Merit Medical Systems Now Expects Full Year 2026 Adjusted EPS Range $4.25 - $4.35, vs. FactSet Est of $4.07

Merit Medical Systems (MMSI) has updated its guidance for the full year 2026, now expecting adjusted EPS to be in the range of $4.25 - $4.35. This revised forecast is notably higher than the FactSet estimate of $4.07. The company had also previously announced …